Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy NantKwest stock
Own NantKwest stock in just a few minutes.
NantKwest, Inc is a biotechnology business based in the US. NantKwest shares (NK) are listed on the NASDAQ and all prices are listed in US Dollars. NantKwest employs 171 staff and has a trailing 12-month revenue of around USD$111,000.
How to buy shares in NantKwest
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for NantKwest. Find the stock by name or ticker symbol: NK. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NantKwest reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NantKwest, depending on your broker.
- Check in on your investment. Congratulations, you own a part of NantKwest. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
NantKwest share price
Use our graph to track the performance of NK stocks over time.NantKwest shares at a glance
Information last updated 2021-03-10.
| 52-week range | USD$2.52 - USD$45.42 |
|---|---|
| 50-day moving average | USD$26.5526 |
| 200-day moving average | USD$13.8949 |
| Wall St. target price | USD$18 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.893 |
Buy NantKwest shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NantKwest stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is NantKwest under- or over-valued?
Valuing NantKwest stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NantKwest's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NantKwest's PEG ratio
NantKwest's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.56. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NantKwest's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
NantKwest financials
| Revenue TTM | USD$111,000 |
|---|---|
| Gross profit TTM | USD$111,000 |
| Return on assets TTM | -36.2% |
| Return on equity TTM | -77.61% |
| Profit margin | 0% |
| Book value | $1.08 |
| Market capitalisation | USD$3.6 billion |
TTM: trailing 12 months
Shorting NantKwest shares
There are currently 3.9 million NantKwest shares held short by investors – that's known as NantKwest's "short interest". This figure is 27.9% down from 5.4 million last month.
There are a few different ways that this level of interest in shorting NantKwest shares can be evaluated.
NantKwest's "short interest ratio" (SIR)
NantKwest's "short interest ratio" (SIR) is the quantity of NantKwest shares currently shorted divided by the average quantity of NantKwest shares traded daily (recently around 1.1 million). NantKwest's SIR currently stands at 3.71. In other words for every 100,000 NantKwest shares traded daily on the market, roughly 3710 shares are currently held short.
However NantKwest's short interest can also be evaluated against the total number of NantKwest shares, or, against the total number of tradable NantKwest shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NantKwest's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 NantKwest shares in existence, roughly 50 shares are currently held short) or 0.1547% of the tradable shares (for every 100,000 tradable NantKwest shares, roughly 155 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NantKwest.
Find out more about how you can short NantKwest stock.
NantKwest share dividends
We're not expecting NantKwest to pay a dividend over the next 12 months.
Have NantKwest's shares ever split?
NantKwest's shares were split on a 8:1 basis on 16 August 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 8 shares. This wouldn't directly have changed the overall worth of your NantKwest shares – just the quantity. However, indirectly, the new 87.5% lower share price could have impacted the market appetite for NantKwest shares which in turn could have impacted NantKwest's share price.
NantKwest share price volatility
Over the last 12 months, NantKwest's shares have ranged in value from as little as $2.52 up to $45.42. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NantKwest's is 2.3862. This would suggest that NantKwest's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NantKwest overview
NantKwest, Inc., a clinical-stage immunotherapy company, develops immunotherapeutic treatments for cancer and viral infectious diseases in the United States. The company develops activated natural killer (aNK) cell, a natural killer cell-line and genetically modified derivative capable of killing cancer and virally infected cells; and Nant cancer vaccine, a personalized therapy that utilizes its off-the-shelf natural killer cells. It is also developing high-affinity natural killer (haNK) product candidates primarily for the treatment of various cancers; and tank and t-haNK product candidates to treat solid tumors. NantKwest, Inc. has a co-development agreement with Altor BioScience, LLC to collaborate on the development of therapeutic applications combining the company's proprietary natural killer cells with Altor's N-801 and/or N-803 products; collaboration with Be The Match BioTherapies for the development of cell therapy to prevent COVID-19 deaths; and strategic alliance with Immunitybio. It also has a collaboration with CBR Systems, Inc. to develop a COVID-19 treatment leveraging newborn stem cells. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in San Diego, California.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert